Tivicay is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Dolutegravir Sodium.
Product ID | 70518-1487_78765cc3-2749-0373-e053-2991aa0a7fe1 |
NDC | 70518-1487 |
Product Type | Human Prescription Drug |
Proprietary Name | Tivicay |
Generic Name | Dolutegravir Sodium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2018-10-06 |
Marketing Category | NDA / NDA |
Application Number | NDA204790 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | DOLUTEGRAVIR SODIUM |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-10-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA204790 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-10-06 |
Ingredient | Strength |
---|---|
DOLUTEGRAVIR SODIUM | 50 mg/1 |
SPL SET ID: | 1721d6f9-8ef7-40c0-8842-ecfe8346a56d |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
49702-226 | Tivicay | dolutegravir sodium |
49702-227 | Tivicay | dolutegravir sodium |
49702-228 | Tivicay | dolutegravir sodium |
50090-1355 | Tivicay | dolutegravir sodium |
53808-1130 | Tivicay | dolutegravir sodium |
67296-1818 | Tivicay | dolutegravir sodium |
70518-1487 | Tivicay | dolutegravir sodium |
49702-255 | Tivicay PD | dolutegravir sodium |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TIVICAY 77509933 not registered Dead/Abandoned |
GLAXOSMITHKLINE LLC 2008-06-27 |
TIVICAY 77063119 3618019 Live/Registered |
VIIV HEALTHCARE COMPANY 2006-12-13 |